Sublimity Therapeutics records €43.2m in accumulated losses
Former Sigmoid Pharma forecasts more losses as it develops ulcerative colitis therapy
Sublimity considers flotation as colitis drug research continues
Irish-founded pharma firm looks to get flagship solution to market by 2025
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices